Expansion of Tennessee-Based Facility for Eastman 168 Non-Phthalate Plasticizer

Eastman Chemical Company announces today that it has successfully completed a further expansion of its manufacturing capacity for Eastman 168™ non-phthalate plasticizer at its Kingsport, Tenn., USA, facility.

A versatile non-phthalate plasticizer for PVC,Eastman 168™ has a long and growing track record of regulatory approvals. It has been demonstrated to be a ready, drop-in replacement for some of the most widely used ortho-phthalate plasticizers that are experiencing regulatory pressure in markets around the world. It finds particular utility in sensitive applications where brand owners are looking for compliance and differentiation, while continuing to provide the same high-performance products for their customers.

“Eastman168™ non-phthalate plasticizer has a history of safe use by manufacturers of consumer products since it was introduced by Eastman more than 30 years ago,” says Dr. Steve Cullen, business manager for plasticizer strategy, Eastman.
This capacity debottleneck will allow increased production of the non-phthalate plasticizer in response to the continuing growth in global customer demand. The approximate 10 percent increase in capacity came on stream at the end of 2010.

“We have seen a rapidly growing demand for Eastman™168 non-phthalate plasticizer in toys, childcare articles, medical devices and a wide range of other consumer applications worldwide, that has led us to increase our supply capacity,” says Cullen. “We believe that Eastman168 is clearly proving to be the best non-phthalate plasticizer on the market today.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.